Production (Stage)
BioSyent Inc.
RX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.27% | -31.90% | 46.51% | -11.97% | 23.02% |
| Total Depreciation and Amortization | -57.30% | 317.60% | -4.50% | -0.94% | 366.56% |
| Total Amortization of Deferred Charges | 357.14% | -85.71% | 8.89% | -- | -- |
| Total Other Non-Cash Items | -92.62% | 461.90% | 2.00% | 63.35% | 42.01% |
| Change in Net Operating Assets | -778.74% | -89.24% | 236.40% | -336.00% | -39.14% |
| Cash from Operations | -126.77% | -61.36% | 538.44% | -255.73% | 42.87% |
| Capital Expenditure | 40.34% | -223.61% | -20.00% | -160.87% | 92.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.32% | 134.85% | -170.38% | 2,360.31% | 133.13% |
| Cash from Investing | 19.34% | 117.08% | -170.60% | 2,384.28% | 131.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.93% | -1.30% | -0.88% | -1.33% | -1.81% |
| Issuance of Common Stock | -63.93% | 223.11% | 32.11% | -- | -- |
| Repurchase of Common Stock | 74.78% | -16,515.79% | 93.83% | 76.56% | -91.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.12% | 4.16% | -0.37% | 2.01% | -11.95% |
| Other Financing Activities | 6.43% | 4.11% | 2.67% | 3.85% | 4.88% |
| Cash from Financing | 64.68% | -637.69% | 39.06% | 58.36% | -69.38% |
| Foreign Exchange rate Adjustments | -102.24% | 217.99% | -9,550.00% | 100.00% | 100.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.34% | -166.27% | -79.19% | 606.51% | 44.70% |